Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
-
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
-
Cellectar Biosciences (CLRB) Announces Pricing of $6 Million Underwritten Public Offering
-
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
-
Cellectar Biosciences (CLRB) Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
-
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
-
UPDATE: Ladenburg Thalmann Assumes Cellectar Biosciences (CLRB) at Buy
-
Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
-
Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences (CLRB) Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering
-
Cellectar Biosciences (CLRB) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock, Warrants
-
Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering
-
Cellectar Biosciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
-
Cellectar Biosciences to Present at the Ladenburg Thalmann 2018 Healthcare Conference
-
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Cellectar Biosciences (CLRB) Prices $14.4M Public Offering at $4/Sh
-
Cellectar Biosciences Announces Pricing of $14.4 Million Underwritten Public OfferingÂ
-
Cellectar Biosciences Announces Successful Completion of $7.76 Million Registered Direct Offering
-
Cellectar Biosciences Announces $7.76 Million Registered Direct Offering Priced At-The-Market
-
Cellectar Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
-
Langenberg Starts Cellectar Biosciences (CLRB) at Buy, $2.70 PT
-
Cellectar Biosciences Announces Successful Completion of $9.2 Million Public Offering, Which Includes Full Exercise of $1.2 Million Over-Allotment Option
-
Cellectar Biosciences (CLRB) Prices Offering at $1.50/Share
-
Cellectar Biosciences Announces Pricing of $8,000,000 Public Offering
-
Cellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference
-
Cellectar Biosciences Announces Successful Completion of $8 Million Public Offering
-
Cellectar Biosciences (CLRB) Prices Common Stock Offering for Gross Proceeds of $7M
-
Cellectar Biosciences Announces Pricing of $7,000,000 Public Offering
-
Cellectar Biosciences Closes on $3.3 Million Financing
-
Cellectar Biosciences Announces Pricing of $3.3 Million Financing
-
Cellectar Biosciences to Present at the Ladenburg Thalmann 2015 Healthcare Conference
-
Cellectar Biosciences to Present at the Ladenburg Thalmann 2015 Healthcare Conference

